Cyp26b1 Mouse 1,2-dichloroethane increases expression EXP 6480464 ethylene dichloride results in increased expression of CYP26B1 mRNA CTD PMID:28189721 and PMID:28960355 Cyp26b1 Mouse 17alpha-ethynylestradiol decreases expression ISO Cyp26b1 (Rattus norvegicus) 6480464 Ethinyl Estradiol results in decreased expression of CYP26B1 mRNA CTD PMID:17557909 Cyp26b1 Mouse 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in increased expression of CYP26B1 mRNA CTD PMID:37844793 Cyp26b1 Mouse 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of CYP26B1 mRNA CTD PMID:31588058 Cyp26b1 Mouse 17alpha-ethynylestradiol decreases expression ISO CYP26B1 (Homo sapiens) 6480464 Ethinyl Estradiol results in decreased expression of CYP26B1 mRNA CTD PMID:18936297 Cyp26b1 Mouse 17beta-estradiol multiple interactions ISO CYP26B1 (Homo sapiens) 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of CYP26B1 mRNA and [Estradiol co-treated with TGFB1 protein] results in increased expression of CYP26B1 mRNA CTD PMID:19619570 and PMID:30165855 Cyp26b1 Mouse 17beta-estradiol increases expression ISO CYP26B1 (Homo sapiens) 6480464 Estradiol results in increased expression of CYP26B1 mRNA CTD PMID:31614463 Cyp26b1 Mouse 17beta-estradiol decreases expression ISO CYP26B1 (Homo sapiens) 6480464 Estradiol results in decreased expression of CYP26B1 mRNA CTD PMID:19619570 and PMID:32088792 Cyp26b1 Mouse 2,2',5,5'-tetrachlorobiphenyl decreases expression ISO CYP26B1 (Homo sapiens) 6480464 2 more ... CTD PMID:36804509 Cyp26b1 Mouse 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO CYP26B1 (Homo sapiens) 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of CYP26B1 mRNA CTD PMID:19619570 Cyp26b1 Mouse 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP26B1 mRNA CTD PMID:28213091 Cyp26b1 Mouse 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Cyp26b1 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP26B1 mRNA CTD PMID:23238561 and PMID:34747641 Cyp26b1 Mouse 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP26B1 mRNA CTD PMID:23238561 Cyp26b1 Mouse 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Cyp26b1 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP26B1 mRNA CTD PMID:19490992 Cyp26b1 Mouse 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO CYP26B1 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP26B1 mRNA CTD PMID:19619570 Cyp26b1 Mouse 2,3,7,8-Tetrachlorodibenzofuran decreases expression ISO Cyp26b1 (Rattus norvegicus) 6480464 2 more ... CTD PMID:32109520 Cyp26b1 Mouse 2,4-D multiple interactions EXP 6480464 [lard co-treated with Cholesterol more ... CTD PMID:37567420 Cyp26b1 Mouse 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects expression EXP 6480464 2 more ... CTD PMID:38648751 Cyp26b1 Mouse 2-hydroxypropanoic acid decreases expression ISO CYP26B1 (Homo sapiens) 6480464 Lactic Acid results in decreased expression of CYP26B1 mRNA CTD PMID:30851411 Cyp26b1 Mouse 4,4'-sulfonyldiphenol increases expression ISO CYP26B1 (Homo sapiens) 6480464 bisphenol S results in increased expression of CYP26B1 mRNA CTD PMID:27685785 Cyp26b1 Mouse 4,4'-sulfonyldiphenol affects methylation EXP 6480464 bisphenol S affects the methylation of CYP26B1 gene CTD PMID:31683443 Cyp26b1 Mouse 4,4'-sulfonyldiphenol multiple interactions ISO Cyp26b1 (Rattus norvegicus) 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CYP26B1 mRNA CTD PMID:36041667 Cyp26b1 Mouse 4,4'-sulfonyldiphenol increases expression EXP 6480464 bisphenol S results in increased expression of CYP26B1 mRNA CTD PMID:30951980 Cyp26b1 Mouse 4-hydroxyphenyl retinamide increases expression ISO Cyp26b1 (Rattus norvegicus) 6480464 Fenretinide results in increased expression of CYP26B1 mRNA CTD PMID:14592467 Cyp26b1 Mouse 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of CYP26B1 mRNA CTD PMID:28973697 Cyp26b1 Mouse 5-aza-2'-deoxycytidine affects expression ISO CYP26B1 (Homo sapiens) 6480464 Decitabine affects the expression of CYP26B1 mRNA CTD PMID:23300844 Cyp26b1 Mouse 6-propyl-2-thiouracil decreases expression ISO Cyp26b1 (Rattus norvegicus) 6480464 Propylthiouracil results in decreased expression of CYP26B1 mRNA CTD PMID:24780913 and PMID:25825206 Cyp26b1 Mouse acetamide increases expression ISO Cyp26b1 (Rattus norvegicus) 6480464 acetamide results in increased expression of CYP26B1 mRNA CTD PMID:31881176 Cyp26b1 Mouse acrylamide decreases expression ISO Cyp26b1 (Rattus norvegicus) 6480464 Acrylamide results in decreased expression of CYP26B1 mRNA CTD PMID:28959563 Cyp26b1 Mouse aldehydo-D-glucose multiple interactions EXP 6480464 [lard co-treated with Cholesterol more ... CTD PMID:37567420 Cyp26b1 Mouse all-trans-retinoic acid affects degradation ISO CYP26B1 (Homo sapiens) 6480464 CYP26B1 protein affects the degradation of Tretinoin CTD PMID:16574820 Cyp26b1 Mouse all-trans-retinoic acid multiple interactions EXP 6480464 [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CYP26B1 mRNA CTD PMID:36189433 Cyp26b1 Mouse all-trans-retinoic acid increases expression ISO CYP26B1 (Homo sapiens) 6480464 Tretinoin results in increased expression of CYP26B1 mRNA CTD PMID:17431108 more ... Cyp26b1 Mouse all-trans-retinoic acid decreases abundance ISO CYP26B1 (Homo sapiens) 6480464 CYP26B1 gene SNP results in decreased abundance of Tretinoin CTD PMID:29379198 Cyp26b1 Mouse all-trans-retinoic acid increases degradation ISO Cyp26b1 (Rattus norvegicus) 6480464 CYP26B1 protein results in increased degradation of Tretinoin CTD PMID:21138835 and PMID:27899881 Cyp26b1 Mouse all-trans-retinoic acid increases expression ISO Cyp26b1 (Rattus norvegicus) 6480464 Tretinoin results in increased expression of CYP26B1 mRNA CTD PMID:14592467 more ... Cyp26b1 Mouse all-trans-retinoic acid multiple interactions ISO Cyp26b1 (Rattus norvegicus) 6480464 [R 115866 results in decreased activity of CYP26B1 protein] which results in increased abundance of Tretinoin and Lipopolysaccharides inhibits the reaction [Tretinoin results in increased expression of CYP26B1 mRNA] CTD PMID:17185629 and PMID:17510468 Cyp26b1 Mouse all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of CYP26B1 mRNA CTD PMID:16688765 Cyp26b1 Mouse all-trans-retinoic acid multiple interactions ISO CYP26B1 (Homo sapiens) 6480464 [R 115866 results in decreased activity of CYP26B1 protein] which results in increased activity of Tretinoin more ... CTD PMID:14532297 more ... Cyp26b1 Mouse all-trans-retinoic acid increases metabolic processing ISO CYP26B1 (Homo sapiens) 6480464 CYP26B1 protein results in increased metabolism of Tretinoin and CYP26B1 results in increased metabolism of Tretinoin CTD PMID:14532297 and PMID:17486130 Cyp26b1 Mouse all-trans-retinoic acid decreases activity ISO CYP26B1 (Homo sapiens) 6480464 CYP26B1 protein results in decreased activity of Tretinoin CTD PMID:20606468 Cyp26b1 Mouse all-trans-retinol multiple interactions ISO Cyp26b1 (Rattus norvegicus) 6480464 [R 115866 co-treated with Vitamin A] results in increased expression of CYP26B1 mRNA CTD PMID:17510468 Cyp26b1 Mouse ammonium chloride affects expression ISO Cyp26b1 (Rattus norvegicus) 6480464 Ammonium Chloride affects the expression of CYP26B1 mRNA CTD PMID:16483693 Cyp26b1 Mouse arecoline decreases expression ISO CYP26B1 (Homo sapiens) 6480464 Arecoline results in decreased expression of CYP26B1 mRNA CTD PMID:17682004 Cyp26b1 Mouse aristolochic acid A increases expression ISO CYP26B1 (Homo sapiens) 6480464 aristolochic acid I results in increased expression of CYP26B1 mRNA CTD PMID:33212167 Cyp26b1 Mouse arotinoid acid multiple interactions ISO CYP26B1 (Homo sapiens) 6480464 [4-(2-(5 more ... CTD PMID:34480604 Cyp26b1 Mouse arsane increases expression EXP 6480464 Arsenic results in increased expression of CYP26B1 mRNA CTD PMID:19654921 Cyp26b1 Mouse arsane affects methylation ISO CYP26B1 (Homo sapiens) 6480464 Arsenic affects the methylation of CYP26B1 gene CTD PMID:25304211 Cyp26b1 Mouse arsenic atom increases expression EXP 6480464 Arsenic results in increased expression of CYP26B1 mRNA CTD PMID:19654921 Cyp26b1 Mouse arsenic atom affects methylation ISO CYP26B1 (Homo sapiens) 6480464 Arsenic affects the methylation of CYP26B1 gene CTD PMID:25304211 Cyp26b1 Mouse arsenite(3-) multiple interactions ISO CYP26B1 (Homo sapiens) 6480464 arsenite inhibits the reaction [G3BP1 protein binds to CYP26B1 mRNA] CTD PMID:32406909 Cyp26b1 Mouse azoxystrobin decreases expression ISO CYP26B1 (Homo sapiens) 6480464 azoxystrobin results in decreased expression of CYP26B1 mRNA CTD PMID:33512557 Cyp26b1 Mouse benzo[a]pyrene multiple interactions EXP 6480464 Benzo(a)pyrene promotes the reaction [AHR protein binds to CYP26B1 promoter] CTD PMID:19654925 Cyp26b1 Mouse benzo[a]pyrene increases expression ISO CYP26B1 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of CYP26B1 mRNA CTD PMID:32234424 Cyp26b1 Mouse benzo[a]pyrene increases methylation EXP 6480464 Benzo(a)pyrene results in increased methylation of CYP26B1 exon and Benzo(a)pyrene results in increased methylation of CYP26B1 intron CTD PMID:27901495 Cyp26b1 Mouse benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of CYP26B1 mRNA CTD PMID:27195522 Cyp26b1 Mouse benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of CYP26B1 mRNA CTD PMID:21569818 Cyp26b1 Mouse benzo[b]fluoranthene decreases expression EXP 6480464 benzo(b)fluoranthene results in decreased expression of CYP26B1 mRNA CTD PMID:26377693 Cyp26b1 Mouse bexarotene increases expression EXP 6480464 bexarotene results in increased expression of CYP26B1 mRNA CTD PMID:17849452 Cyp26b1 Mouse bis(2-ethylhexyl) phthalate multiple interactions ISO Cyp26b1 (Rattus norvegicus) 6480464 [diisobutyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate] results in increased expression of CYP26B1 mRNA CTD PMID:37788136 Cyp26b1 Mouse bisphenol A increases expression ISO Cyp26b1 (Rattus norvegicus) 6480464 bisphenol A results in increased expression of CYP26B1 mRNA CTD PMID:25181051 Cyp26b1 Mouse bisphenol A multiple interactions ISO Cyp26b1 (Rattus norvegicus) 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CYP26B1 mRNA CTD PMID:36041667 Cyp26b1 Mouse bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CYP26B1 mRNA CTD PMID:32365465 and PMID:33221593 Cyp26b1 Mouse bisphenol A decreases expression ISO Cyp26b1 (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of CYP26B1 mRNA CTD PMID:32145629 Cyp26b1 Mouse bisphenol F increases expression EXP 6480464 bisphenol F results in increased expression of CYP26B1 mRNA CTD PMID:30951980 Cyp26b1 Mouse bisphenol F multiple interactions ISO Cyp26b1 (Rattus norvegicus) 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CYP26B1 mRNA CTD PMID:36041667 Cyp26b1 Mouse bromobenzene decreases expression ISO Cyp26b1 (Rattus norvegicus) 6480464 bromobenzene results in decreased expression of CYP26B1 mRNA CTD PMID:32479839 Cyp26b1 Mouse Butylbenzyl phthalate multiple interactions ISO Cyp26b1 (Rattus norvegicus) 6480464 [diisobutyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate] results in increased expression of CYP26B1 mRNA CTD PMID:37788136 Cyp26b1 Mouse C60 fullerene decreases expression ISO Cyp26b1 (Rattus norvegicus) 6480464 fullerene C60 results in decreased expression of CYP26B1 mRNA CTD PMID:19167457 Cyp26b1 Mouse cadmium atom decreases expression EXP 6480464 Cadmium results in decreased expression of CYP26B1 mRNA CTD PMID:19556237 Cyp26b1 Mouse calcitriol increases expression ISO CYP26B1 (Homo sapiens) 6480464 Calcitriol results in increased expression of CYP26B1 mRNA CTD PMID:16002434 and PMID:26485663 Cyp26b1 Mouse camptothecin decreases response to substance ISO CYP26B1 (Homo sapiens) 6480464 CYP26B1 mRNA results in decreased susceptibility to Camptothecin CTD PMID:25269479 Cyp26b1 Mouse carbon nanotube increases expression EXP 6480464 Nanotubes more ... CTD PMID:25620056 Cyp26b1 Mouse CGP 52608 multiple interactions ISO CYP26B1 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to CYP26B1 gene] CTD PMID:28238834 Cyp26b1 Mouse CHIR 99021 multiple interactions ISO CYP26B1 (Homo sapiens) 6480464 [4-(2-(5 more ... CTD PMID:34480604 Cyp26b1 Mouse chloroprene decreases expression ISO Cyp26b1 (Rattus norvegicus) 6480464 Chloroprene results in decreased expression of CYP26B1 mRNA CTD PMID:23125180 Cyp26b1 Mouse choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CYP26B1 gene CTD PMID:20938992 Cyp26b1 Mouse cisplatin decreases expression ISO Cyp26b1 (Rattus norvegicus) 6480464 Cisplatin results in decreased expression of CYP26B1 mRNA CTD PMID:22023808 Cyp26b1 Mouse cisplatin decreases expression ISO CYP26B1 (Homo sapiens) 6480464 Cisplatin results in decreased expression of CYP26B1 mRNA CTD PMID:27392435 Cyp26b1 Mouse cisplatin multiple interactions ISO CYP26B1 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of CYP26B1 mRNA CTD PMID:27392435 Cyp26b1 Mouse cisplatin affects expression ISO CYP26B1 (Homo sapiens) 6480464 Cisplatin affects the expression of CYP26B1 mRNA CTD PMID:23300844 Cyp26b1 Mouse cocaine decreases response to substance ISO Cyp26b1 (Rattus norvegicus) 6480464 CYP26B1 protein results in decreased susceptibility to Cocaine CTD PMID:27899881 Cyp26b1 Mouse copper(II) sulfate increases expression ISO CYP26B1 (Homo sapiens) 6480464 Copper Sulfate results in increased expression of CYP26B1 mRNA CTD PMID:19549813 Cyp26b1 Mouse cortisol multiple interactions ISO CYP26B1 (Homo sapiens) 6480464 [4-(2-(5 more ... CTD PMID:34480604 Cyp26b1 Mouse cyhalothrin decreases expression ISO Cyp26b1 (Rattus norvegicus) 6480464 cyhalothrin results in decreased expression of CYP26B1 mRNA CTD PMID:29727961 Cyp26b1 Mouse cypermethrin decreases expression EXP 6480464 cypermethrin results in decreased expression of CYP26B1 mRNA CTD PMID:31659573 Cyp26b1 Mouse cypermethrin multiple interactions EXP 6480464 Sodium Selenite inhibits the reaction [cypermethrin results in decreased expression of CYP26B1 mRNA] CTD PMID:31659573 Cyp26b1 Mouse cyproconazole increases expression EXP 6480464 cyproconazole results in increased expression of CYP26B1 mRNA CTD PMID:22045034 Cyp26b1 Mouse D-glucose multiple interactions EXP 6480464 [lard co-treated with Cholesterol more ... CTD PMID:37567420 Cyp26b1 Mouse deguelin decreases expression ISO CYP26B1 (Homo sapiens) 6480464 deguelin results in decreased expression of CYP26B1 mRNA CTD PMID:33512557 Cyp26b1 Mouse dextran sulfate decreases expression EXP 6480464 Dextran Sulfate results in decreased expression of CYP26B1 mRNA CTD PMID:35093514 Cyp26b1 Mouse dibenz[a,h]anthracene decreases expression EXP 6480464 1 more ... CTD PMID:26377693 Cyp26b1 Mouse dibutyl phthalate multiple interactions ISO Cyp26b1 (Rattus norvegicus) 6480464 [diisobutyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate] results in increased expression of CYP26B1 mRNA CTD PMID:37788136 Cyp26b1 Mouse diclofenac multiple interactions EXP 6480464 [Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in increased expression of CYP26B1 mRNA CTD PMID:37844793 Cyp26b1 Mouse diethyl maleate decreases expression ISO Cyp26b1 (Rattus norvegicus) 6480464 diethyl maleate results in decreased expression of CYP26B1 mRNA CTD PMID:21161181 Cyp26b1 Mouse diethylstilbestrol increases expression ISO CYP26B1 (Homo sapiens) 6480464 Diethylstilbestrol results in increased expression of CYP26B1 mRNA CTD PMID:32088792 Cyp26b1 Mouse diisobutyl phthalate multiple interactions ISO Cyp26b1 (Rattus norvegicus) 6480464 [diisobutyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate] results in increased expression of CYP26B1 mRNA CTD PMID:37788136 Cyp26b1 Mouse diisononyl phthalate multiple interactions ISO Cyp26b1 (Rattus norvegicus) 6480464 [diisobutyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate] results in increased expression of CYP26B1 mRNA CTD PMID:37788136 Cyp26b1 Mouse dioxygen multiple interactions ISO Cyp26b1 (Rattus norvegicus) 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CYP26B1 mRNA CTD PMID:33729688 Cyp26b1 Mouse diquat increases expression EXP 6480464 Diquat results in increased expression of CYP26B1 mRNA CTD PMID:36851058 Cyp26b1 Mouse disodium selenite multiple interactions EXP 6480464 Sodium Selenite inhibits the reaction [cypermethrin results in decreased expression of CYP26B1 mRNA] CTD PMID:31659573 Cyp26b1 Mouse diuron increases expression ISO Cyp26b1 (Rattus norvegicus) 6480464 Diuron metabolite results in increased expression of CYP26B1 mRNA CTD PMID:24172598 Cyp26b1 Mouse doxorubicin decreases expression ISO CYP26B1 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of CYP26B1 mRNA CTD PMID:29803840 Cyp26b1 Mouse endosulfan increases expression ISO Cyp26b1 (Rattus norvegicus) 6480464 Endosulfan results in increased expression of CYP26B1 mRNA CTD PMID:29391264 Cyp26b1 Mouse fipronil increases expression ISO CYP26B1 (Homo sapiens) 6480464 fipronil results in increased expression of CYP26B1 mRNA CTD PMID:27091632 Cyp26b1 Mouse fipronil multiple interactions ISO CYP26B1 (Homo sapiens) 6480464 [fipronil co-treated with DEET] results in increased expression of CYP26B1 mRNA CTD PMID:27091632 Cyp26b1 Mouse fluconazole increases expression EXP 6480464 Fluconazole results in increased expression of CYP26B1 mRNA CTD PMID:19429397 Cyp26b1 Mouse fluoxetine decreases expression ISO Cyp26b1 (Rattus norvegicus) 6480464 Fluoxetine results in decreased expression of CYP26B1 mRNA CTD PMID:17033635 Cyp26b1 Mouse flusilazole increases expression ISO Cyp26b1 (Rattus norvegicus) 6480464 flusilazole results in increased expression of CYP26B1 mRNA CTD PMID:28263823 Cyp26b1 Mouse folic acid multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CYP26B1 gene CTD PMID:20938992 Cyp26b1 Mouse folic acid decreases expression EXP 6480464 Folic Acid results in decreased expression of CYP26B1 mRNA CTD PMID:25629700 Cyp26b1 Mouse fructose multiple interactions EXP 6480464 [lard co-treated with Cholesterol more ... CTD PMID:37567420 Cyp26b1 Mouse furan increases expression ISO Cyp26b1 (Rattus norvegicus) 6480464 furan results in increased expression of CYP26B1 mRNA CTD PMID:25539665 and PMID:27387713 Cyp26b1 Mouse furan decreases methylation ISO Cyp26b1 (Rattus norvegicus) 6480464 furan results in decreased methylation of CYP26B1 gene CTD PMID:27387713 Cyp26b1 Mouse genistein increases expression EXP 6480464 Genistein results in increased expression of CYP26B1 mRNA CTD PMID:32186404 Cyp26b1 Mouse gentamycin decreases expression ISO Cyp26b1 (Rattus norvegicus) 6480464 Gentamicins results in decreased expression of CYP26B1 mRNA CTD PMID:33387578 Cyp26b1 Mouse glucose multiple interactions EXP 6480464 [lard co-treated with Cholesterol more ... CTD PMID:37567420 Cyp26b1 Mouse hexaconazole increases expression EXP 6480464 hexaconazole results in increased expression of CYP26B1 mRNA CTD PMID:22045034 Cyp26b1 Mouse hexadecanoic acid multiple interactions ISO CYP26B1 (Homo sapiens) 6480464 [Palmitic Acid co-treated with Oleic Acid] results in increased expression of CYP26B1 mRNA CTD PMID:30547786 Cyp26b1 Mouse ibuprofen multiple interactions EXP 6480464 [Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in increased expression of CYP26B1 mRNA CTD PMID:37844793 Cyp26b1 Mouse isoprenaline decreases expression EXP 6480464 Isoproterenol results in decreased expression of CYP26B1 mRNA CTD PMID:20003209 Cyp26b1 Mouse isotretinoin multiple interactions ISO CYP26B1 (Homo sapiens) 6480464 R116010 promotes the reaction [Isotretinoin results in increased expression of CYP26B1 mRNA] CTD PMID:17486130 Cyp26b1 Mouse isotretinoin increases expression ISO CYP26B1 (Homo sapiens) 6480464 Isotretinoin results in increased expression of CYP26B1 mRNA CTD PMID:17486130 and PMID:18769122 Cyp26b1 Mouse ketoconazole multiple interactions ISO CYP26B1 (Homo sapiens) 6480464 Ketoconazole inhibits the reaction [CYP26B1 protein results in increased metabolism of Tretinoin] and Ketoconazole inhibits the reaction [CYP26B1 results in increased metabolism of Tretinoin] CTD PMID:14532297 and PMID:21906690 Cyp26b1 Mouse ketoconazole decreases activity ISO CYP26B1 (Homo sapiens) 6480464 Ketoconazole results in decreased activity of CYP26B1 CTD PMID:14532297 Cyp26b1 Mouse kojic acid increases expression ISO CYP26B1 (Homo sapiens) 6480464 kojic acid results in increased expression of CYP26B1 mRNA CTD PMID:16595896 Cyp26b1 Mouse L-ascorbic acid multiple interactions ISO CYP26B1 (Homo sapiens) 6480464 [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of CYP26B1 mRNA CTD PMID:34480604 Cyp26b1 Mouse L-ascorbic acid 2-phosphate multiple interactions ISO CYP26B1 (Homo sapiens) 6480464 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of CYP26B1 mRNA CTD PMID:34480604 Cyp26b1 Mouse L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CYP26B1 gene CTD PMID:20938992 Cyp26b1 Mouse leflunomide decreases expression EXP 6480464 leflunomide results in decreased expression of CYP26B1 mRNA CTD PMID:19751817 Cyp26b1 Mouse lipopolysaccharide multiple interactions ISO Cyp26b1 (Rattus norvegicus) 6480464 Lipopolysaccharides inhibits the reaction [Tretinoin results in increased expression of CYP26B1 mRNA] CTD PMID:17185629 Cyp26b1 Mouse lipopolysaccharide increases expression ISO CYP26B1 (Homo sapiens) 6480464 Lipopolysaccharides results in increased expression of CYP26B1 mRNA CTD PMID:35811015 Cyp26b1 Mouse lipopolysaccharide multiple interactions ISO CYP26B1 (Homo sapiens) 6480464 S-(1 and 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of CYP26B1 mRNA] CTD PMID:35811015 Cyp26b1 Mouse manganese atom decreases expression ISO Cyp26b1 (Rattus norvegicus) 6480464 Manganese results in decreased expression of CYP26B1 mRNA CTD PMID:26745496 Cyp26b1 Mouse manganese(0) decreases expression ISO Cyp26b1 (Rattus norvegicus) 6480464 Manganese results in decreased expression of CYP26B1 mRNA CTD PMID:26745496 Cyp26b1 Mouse manganese(II) chloride decreases expression ISO Cyp26b1 (Rattus norvegicus) 6480464 manganese chloride results in decreased expression of CYP26B1 mRNA CTD PMID:26745496 Cyp26b1 Mouse methoxychlor increases expression ISO Cyp26b1 (Rattus norvegicus) 6480464 Methoxychlor results in increased expression of CYP26B1 mRNA CTD PMID:23303685 Cyp26b1 Mouse methoxychlor increases methylation ISO Cyp26b1 (Rattus norvegicus) 6480464 Methoxychlor results in increased methylation of CYP26B1 gene CTD PMID:23303685 Cyp26b1 Mouse mono(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CYP26B1 mRNA CTD PMID:36189433 Cyp26b1 Mouse N,N-diethyl-m-toluamide multiple interactions ISO CYP26B1 (Homo sapiens) 6480464 [fipronil co-treated with DEET] results in increased expression of CYP26B1 mRNA CTD PMID:27091632 Cyp26b1 Mouse nitrofen decreases expression ISO Cyp26b1 (Rattus norvegicus) 6480464 nitrofen results in decreased expression of CYP26B1 mRNA CTD PMID:17203325 and PMID:26720608 Cyp26b1 Mouse oleic acid multiple interactions ISO CYP26B1 (Homo sapiens) 6480464 [Palmitic Acid co-treated with Oleic Acid] results in increased expression of CYP26B1 mRNA CTD PMID:30547786 Cyp26b1 Mouse oxaliplatin increases expression ISO Cyp26b1 (Rattus norvegicus) 6480464 oxaliplatin results in increased expression of CYP26B1 mRNA CTD PMID:25729387 Cyp26b1 Mouse oxaliplatin multiple interactions ISO Cyp26b1 (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of CYP26B1 mRNA CTD PMID:25729387 Cyp26b1 Mouse paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of CYP26B1 mRNA CTD PMID:17562736 Cyp26b1 Mouse paracetamol increases expression ISO Cyp26b1 (Rattus norvegicus) 6480464 Acetaminophen results in increased expression of CYP26B1 mRNA CTD PMID:33387578 Cyp26b1 Mouse paraquat increases expression EXP 6480464 Paraquat results in increased expression of CYP26B1 mRNA CTD PMID:21371552 Cyp26b1 Mouse perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of CYP26B1 mRNA CTD PMID:36331819 Cyp26b1 Mouse perfluorooctanoic acid increases expression ISO Cyp26b1 (Rattus norvegicus) 6480464 perfluorooctanoic acid results in increased expression of CYP26B1 mRNA CTD PMID:28511854 Cyp26b1 Mouse phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of CYP26B1 mRNA CTD PMID:23091169 Cyp26b1 Mouse phenobarbital increases expression ISO CYP26B1 (Homo sapiens) 6480464 Phenobarbital results in increased expression of CYP26B1 mRNA CTD PMID:22258563 Cyp26b1 Mouse phenylephrine increases expression ISO Cyp26b1 (Rattus norvegicus) 6480464 Phenylephrine results in increased expression of CYP26B1 mRNA CTD PMID:18158353 Cyp26b1 Mouse picoxystrobin decreases expression ISO CYP26B1 (Homo sapiens) 6480464 picoxystrobin results in decreased expression of CYP26B1 mRNA CTD PMID:33512557 Cyp26b1 Mouse quercitrin increases expression ISO CYP26B1 (Homo sapiens) 6480464 quercitrin results in increased expression of CYP26B1 mRNA CTD PMID:25193878 Cyp26b1 Mouse quinalphos decreases expression EXP 6480464 quinalphos results in decreased expression of CYP26B1 mRNA CTD PMID:24581381 Cyp26b1 Mouse quinalphos multiple interactions EXP 6480464 Plant Extracts inhibits the reaction [quinalphos results in decreased expression of CYP26B1 mRNA] CTD PMID:24581381 Cyp26b1 Mouse quinolines multiple interactions ISO CYP26B1 (Homo sapiens) 6480464 Quinolines analog inhibits the reaction [Tretinoin results in increased expression of CYP26B1 mRNA] CTD PMID:35483669 Cyp26b1 Mouse rac-lactic acid decreases expression ISO CYP26B1 (Homo sapiens) 6480464 Lactic Acid results in decreased expression of CYP26B1 mRNA CTD PMID:30851411 Cyp26b1 Mouse raloxifene multiple interactions ISO CYP26B1 (Homo sapiens) 6480464 [Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of CYP26B1 mRNA CTD PMID:19059307 Cyp26b1 Mouse resveratrol multiple interactions ISO Cyp26b1 (Rattus norvegicus) 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of CYP26B1 mRNA CTD PMID:25905778 Cyp26b1 Mouse S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO CYP26B1 (Homo sapiens) 6480464 S-(1 and 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of CYP26B1 mRNA] CTD PMID:35811015 Cyp26b1 Mouse SB 431542 multiple interactions ISO CYP26B1 (Homo sapiens) 6480464 [LDN 193189 co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of CYP26B1 mRNA CTD PMID:34480604 Cyp26b1 Mouse silicon dioxide decreases expression ISO CYP26B1 (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of CYP26B1 mRNA CTD PMID:25895662 Cyp26b1 Mouse silicon dioxide decreases expression EXP 6480464 Silicon Dioxide results in decreased expression of CYP26B1 mRNA CTD PMID:29341224 Cyp26b1 Mouse silicon dioxide increases expression ISO CYP26B1 (Homo sapiens) 6480464 Silicon Dioxide analog results in increased expression of CYP26B1 mRNA CTD PMID:23806026 Cyp26b1 Mouse sodium arsenite decreases expression ISO CYP26B1 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of CYP26B1 mRNA CTD PMID:34032870 Cyp26b1 Mouse sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of CYP26B1 mRNA CTD PMID:36209798 Cyp26b1 Mouse Soman increases expression ISO Cyp26b1 (Rattus norvegicus) 6480464 Soman results in increased expression of CYP26B1 mRNA CTD PMID:19281266 Cyp26b1 Mouse sotorasib multiple interactions ISO CYP26B1 (Homo sapiens) 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of CYP26B1 mRNA CTD PMID:36139627 Cyp26b1 Mouse streptozocin multiple interactions ISO Cyp26b1 (Rattus norvegicus) 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of CYP26B1 mRNA CTD PMID:25905778 Cyp26b1 Mouse sulforaphane multiple interactions EXP 6480464 [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of CYP26B1 mRNA CTD PMID:30529165 Cyp26b1 Mouse sunitinib decreases expression ISO CYP26B1 (Homo sapiens) 6480464 Sunitinib results in decreased expression of CYP26B1 mRNA CTD PMID:31533062 Cyp26b1 Mouse tamoxifen decreases expression EXP 6480464 Tamoxifen results in decreased expression of CYP26B1 mRNA CTD PMID:25123088 Cyp26b1 Mouse tamoxifen multiple interactions ISO CYP26B1 (Homo sapiens) 6480464 [Tamoxifen co-treated with ESR2 protein] results in decreased expression of CYP26B1 mRNA CTD PMID:19059307 Cyp26b1 Mouse titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of CYP26B1 mRNA CTD PMID:23557971 Cyp26b1 Mouse titanium dioxide decreases expression ISO Cyp26b1 (Rattus norvegicus) 6480464 titanium dioxide results in decreased expression of CYP26B1 mRNA CTD PMID:30012374 Cyp26b1 Mouse toluene affects expression ISO Cyp26b1 (Rattus norvegicus) 6480464 Toluene affects the expression of CYP26B1 mRNA CTD PMID:18653662 Cyp26b1 Mouse topotecan multiple interactions ISO Cyp26b1 (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of CYP26B1 mRNA CTD PMID:25729387 Cyp26b1 Mouse topotecan increases expression ISO Cyp26b1 (Rattus norvegicus) 6480464 Topotecan results in increased expression of CYP26B1 mRNA CTD PMID:25729387 Cyp26b1 Mouse trametinib multiple interactions ISO CYP26B1 (Homo sapiens) 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of CYP26B1 mRNA CTD PMID:36139627 Cyp26b1 Mouse trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of CYP26B1 mRNA CTD PMID:25549359 Cyp26b1 Mouse trichloroethene decreases expression ISO Cyp26b1 (Rattus norvegicus) 6480464 Trichloroethylene results in decreased expression of CYP26B1 mRNA CTD PMID:33387578 Cyp26b1 Mouse trichostatin A increases expression ISO CYP26B1 (Homo sapiens) 6480464 trichostatin A results in increased expression of CYP26B1 mRNA CTD PMID:24935251 Cyp26b1 Mouse trimellitic anhydride decreases expression EXP 6480464 trimellitic anhydride results in decreased expression of CYP26B1 mRNA CTD PMID:19042947 Cyp26b1 Mouse triphenyl phosphate decreases expression ISO Cyp26b1 (Rattus norvegicus) 6480464 triphenyl phosphate results in decreased expression of CYP26B1 mRNA CTD PMID:30589522 Cyp26b1 Mouse valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of CYP26B1 mRNA CTD PMID:17292431 Cyp26b1 Mouse valproic acid increases expression ISO CYP26B1 (Homo sapiens) 6480464 Valproic Acid results in increased expression of CYP26B1 mRNA CTD PMID:24383497 and PMID:28001369 Cyp26b1 Mouse valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of CYP26B1 mRNA CTD PMID:22045034 Cyp26b1 Mouse vinclozolin increases expression ISO Cyp26b1 (Rattus norvegicus) 6480464 vinclozolin results in increased expression of CYP26B1 mRNA CTD PMID:20566332 Cyp26b1 Mouse vinyl carbamate decreases expression EXP 6480464 vinyl carbamate results in decreased expression of CYP26B1 mRNA CTD PMID:17849452 Cyp26b1 Mouse XAV939 multiple interactions ISO CYP26B1 (Homo sapiens) 6480464 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of CYP26B1 mRNA and [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of CYP26B1 mRNA CTD PMID:34480604